🔎 Trials Near Me

Home › Diffuse Large B-Cell Lymphoma › New Jersey

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa New Jersey

13 pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa New Jersey.

Mga Lungsod sa New Jersey

Opisyal na teksto ng pag-aaral (English)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

  • Atlantic Health Morristown Medical Center ( Site 0163), Morristown
  • Valley Health Systems - Ridgewood Campus ( Site 0125), Paramus
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06890884

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  • Rutgers Cancer Institute of New Jersey, New Brunswick
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06091865

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • Rutgers Cancer Institute of New Jersey, New Brunswick
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

  • Astera Cancer Care, East Brunswick
  • John Theurer Cancer Center, Hackensack
  • Rutgers Cancer Institute of New Jersey, New Brunswick
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06500273

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • John Theurer Cancer Center Hackensack University Medical Center, Hackensack
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Hackensack, Hackensack
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  • START New Jersey, East Brunswick
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07424833

A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Hackensack Meridian Health (Data collection only), Hackensack
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • at 1 pa
Nagre-recruitPhase 2
Edad 65 hanggang 80 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06765317

SynKIR-310 for Relapsed/Refractory B-NHL

  • Rutgers Cancer Institute, New Brunswick
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT06544265

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT04512716

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT06736613

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

  • Hackensack University Medical Center, Hackensack
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 26, 2024 · NCT06238648

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.